Fundraising FoxFREEFLOW — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Erg Bio converts waste biomass into fermentable sugars and intermediates for synthetic aviation fuels and chemicals, using an advanced solvent process and a proprietary yeast that produces enzymes and ferments sugars.
BiotechCleantechEnergyDublin, US
Vineet Rajgarhia(Co-founder & CEO)inBlake Simmons(Co-founder & CTO)inMichael Rabson(Co-founder & Strategic Advisor)in
Co-investorsAzolla VenturesJuniperLichen VenturesChevron Technology Ventures
.jpeg){kind=logo}
Sift Biosciences develops T-cell immunotherapies for cancer and autoimmune diseases, using an AI-driven discovery platform combined with metagenomics and high-throughput cellular screening to identify microbially derived molecules that activate memory T cells.
AI & Machine LearningBiotechHealthtechSan Carlos, US
Yue Clare Lou(Co-Founder & CEO)in
BoardKevin Barrett(Director)inAltar Munis(Director)
Co-investorsEisai Innovation, Inc.SBI HoldingsFifty YearsLifespan Vision Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.